Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Estimated Value: $10,000,000
Open Healthcaregrant
Feb 12, 2026
Healthcare
grant
AI Summary
This grant opportunity (RFA-NS-26-030) from NIH supports clinical trials and research related to genomic and biologic therapies for Alzheimer's Disease and Related Dementias (ADRD). The funding is available through CFDA 93.853.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Genomic Therapy Research Services 1 lot $2,000,000.00 $2,000,000.00 Medical
Biologic Therapy Research Services 1 lot $2,000,000.00 $2,000,000.00 Medical
Clinical Trial Services (ADRD) 1 lot $3,000,000.00 $3,000,000.00 Medical
Data Analysis and Statistical Support 1 lot $500,000.00 $500,000.00 Professional Services
Project Management Services 1 lot $500,000.00 $500,000.00 Professional Services
Regulatory Compliance Services 1 lot $500,000.00 $500,000.00 Professional Services
Patient Recruitment and Retention Services 1 lot $1,000,000.00 $1,000,000.00 Medical
Laboratory Services 1 lot $500,000.00 $500,000.00 Medical
Estimated Bid Value$10,000,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids